(0.20%) 5 110.21 points
(0.28%) 38 345 points
(0.11%) 15 946 points
(-0.42%) $83.50
(2.44%) $1.970
(-0.12%) $2 344.30
(-0.38%) $27.43
(2.72%) $947.15
(0.03%) $0.935
(-0.03%) $11.02
(-0.21%) $0.799
(1.92%) $93.64
-6.26% HKD 20.20
Live Chart Being Loaded With Signals
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China...
Stats | |
---|---|
Объем за сегодня | 18.07M |
Средний объем | 5.10M |
Рыночная капитализация | 63.00B |
EPS | HKD0 ( 2024-04-25 ) |
Last Dividend | HKD0.901 ( 2023-06-19 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 6.45 |
ATR14 | HKD0.0460 (0.23%) |
Объем Корреляция
SINOPHARM GROUP CO LTD Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
SINOPHARM GROUP CO LTD Корреляция - Валюта/Сырье
SINOPHARM GROUP CO LTD Финансовые показатели
Annual | 2023 |
Выручка: | HKD596.57B |
Валовая прибыль: | HKD48.51B (8.13 %) |
EPS: | HKD2.90 |
FY | 2023 |
Выручка: | HKD596.57B |
Валовая прибыль: | HKD48.51B (8.13 %) |
EPS: | HKD2.90 |
FY | 2022 |
Выручка: | HKD552.15B |
Валовая прибыль: | HKD47.43B (8.59 %) |
EPS: | HKD4.60 |
FY | 2021 |
Выручка: | HKD521.05B |
Валовая прибыль: | HKD44.05B (8.45 %) |
EPS: | HKD2.49 |
Financial Reports:
No articles found.
SINOPHARM GROUP CO LTD Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.901 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0101 | 2010-04-29 |
Last Dividend | HKD0.901 | 2023-06-19 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | HKD6.94 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.6 | -- |
Div. Sustainability Score | 9.69 | |
Div.Growth Potential Score | 3.37 | |
Div. Directional Score | 6.53 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
0308.HK | Ex Dividend Junior | 2023-09-18 | Annually | 0 | 0.00% | |
3993.HK | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% | |
1800.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
0836.HK | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
0002.HK | Ex Dividend Knight | 2023-09-04 | Quarterly | 0 | 0.00% | |
2382.HK | Ex Dividend Junior | 2023-05-30 | Annually | 0 | 0.00% | |
1373.HK | Ex Dividend Knight | 2023-10-04 | Semi-Annually | 0 | 0.00% | |
0435.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% | |
6812.HK | Ex Dividend Junior | 2023-08-04 | Sporadic | 0 | 0.00% | |
1919.HK | Ex Dividend Knight | 2023-05-30 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0155 | 1.500 | 9.69 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0358 | 1.200 | 8.81 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.194 | 1.500 | 8.96 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.395 | 0.800 | 8.03 | 6.42 | [1 - 3] |
quickRatioTTM | 1.034 | 0.800 | 8.63 | 6.90 | [0.8 - 2.5] |
cashRatioTTM | 0.264 | 1.500 | 9.64 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.188 | -1.500 | 6.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 20.69 | 1.000 | 3.45 | 3.45 | [3 - 30] |
operatingCashFlowPerShareTTM | 23.49 | 2.00 | 2.17 | 4.34 | [0 - 30] |
freeCashFlowPerShareTTM | 22.23 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.965 | -1.500 | 6.14 | -9.21 | [0 - 2.5] |
grossProfitMarginTTM | 0.0838 | 1.000 | -1.937 | -1.937 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0381 | 1.000 | -1.238 | -1.238 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.017 | 1.000 | 5.46 | 5.46 | [0.2 - 2] |
assetTurnoverTTM | 2.31 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 9.69 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.31 | 1.000 | 9.67 | 0 | [1 - 100] |
returnOnEquityTTM | 0.194 | 2.50 | 9.33 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 22.23 | 2.00 | 2.59 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.75 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 23.49 | 2.00 | 2.17 | 4.34 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0 | 1.500 | -3.33 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0825 | 1.000 | -0.437 | 0 | [0.1 - 0.5] |
Total Score | 3.37 |
SINOPHARM GROUP CO LTD
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа